LONDON, Sept. 12 /PRNewswire-FirstCall/ -- A key new radiography skills center opens in London today, backed by equipment donated by Varian Medical Systems, world leader in radiotherapy for battling cancer. The Saad Centre for Radiography Clinical Skills Education will provide a major boost in training future radiotherapy radiographers. As its contribution to the project, Varian has donated ten Eclipse(TM) treatment planning systems (TPS). Eclipse is the world's most popular radiotherapy TPS, enabling oncologists to plan advanced treatments using the latest radiotherapy techniques such as image-guided radiotherapy (IGRT) and intensity modulated radiotherapy (IMRT). The new facility, the first in the south of England, has been made possible thanks to investment by London's City University, the Saad Group from Saudi Arabia and Varian. The new state-of-the-art complex will raise standards of training in radiography and ensure graduates receive the most advanced practical experience in the UK. Michael Sandhu, Varian's European director of public/private partnerships, says, "This new center will be a major resource in training radiotherapy radiographers of the future and we are proud to support such a vital and worthwhile project. More trained radiographers mean more staff to run the additional treatment machines acquired in the UK in recent years, and this will greatly benefit the country's cancer patients in the future." Varian also supports England's only other radiography skills lab, based at Sheffield Hallam University and covering the north of the country. "Facilities such as those at Sheffield and now in London are vital in enabling new advances in radiotherapy to be put into practice," adds Sandhu. "A shortage of qualified radiographers has sometimes prevented such techniques from being implemented as swiftly as necessary in the past, as existing clinical staff battle to control waiting lists. We want that to change, as every patient deserves the opportunity to be treated with the most effective technology that gives them the best chance of a cure." Jennifer Edie, Head of Radiography at The City University, London says: "The range and sophistication of these facilities mean that our radiography courses are more practical than ever, fully equipping all graduates for the world of work and taking the strain off busy hospital staff." The center's development began after a group of the University's radiographers debated the future needs of the University's training for the profession. The conclusion was a two-phase project: the first phase saw the construction of the radiography clinical skills center and the inclusion of new clinical equipment and facilities. The second phase is focused on increasing the center's research to place it at the forefront of the radiography profession. The Saad Centre plans to dramatically increase its radiography research and offer more training and development opportunities to students and practicing radiographers across the UK and worldwide. The center also benefits from having close links with the department of radiography's radiation laboratory, which is dedicated to researching the interactions between radiation and different body tissues. The new facility comes on the back of significant recent government investment in radiotherapy equipment. Over the last three years, the UK government's Purchasing and Supply Agency (PASA) has announced major radiotherapy investments in a series of waves. More than 100 new linear accelerators have been acquired as part of the Cancer Plan and Varian has been selected to provide two-thirds of all machines ordered. Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068, http://www.varian.com/ Media tours of the new Saad Centre are available on request by contacting Helena Clay in the City University press office on +44 207 040 8788 or via About Varian Medical Systems Varian Medical Systems, Inc., of Palo Alto, California is the world's leading manufacturer of medical technology for treating cancer with radiotherapy and neurological conditions with radiosurgery. The company is also a premier supplier of X-ray tubes and flat-panel digital subsystems for imaging in medical, scientific, and industrial applications. Varian Medical Systems employs approximately 3,600 people who are located at manufacturing sites in North America and Europe and in its 56 sales and support offices around the world. In Europe, the company operates manufacturing and engineering centers in Baden (Switzerland), Crawley (England), Haan (Germany), Helsinki (Finland) and Toulouse (France) and has headquarters for Europe, Middle East, India and Africa (EMEA) based in Zug, Switzerland. Additional information is available on the company's web site at http://www.varian.com/ Forward Looking Statements Statements in this press release regarding future business, events, plans, objectives, expectations, estimates, and other similar matters, including, but not limited to, statements using the terms "can" and "expect," constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements contained in this press release are subject to risks and uncertainties that could cause actual results to differ materially from those anticipated, including, but not limited to, the risks described in the Company's Annual Report on Form 10-K and other reports filed from time to time by the Company with the U.S. Securities and Exchange Commission. These forward-looking statements represent the Company's judgment as of the date of this press release. The Company assumes no obligation to update or revise these forward-looking statements because of new information, future events, or otherwise. Furthermore, notwithstanding any specific events announced in this press release, the Company's quarterly and annual financial results are subject to such risks and uncertainties described in the Company's Annual Report on Form 10-K and other reports filed from time to time by the Company with the U.S. Securities and Exchange Commission and actual results may differ materially from those anticipated. DATASOURCE: Varian Medical Systems CONTACT: Neil Madle of Varian Medical Systems, +44 7786 526068, or Web site: http://www.varian.com/

Copyright